Similar articles for PMID: 17971424

Year	Number of Results
1977	1
1979	1
1980	1
1981	1
1982	1
1986	1
1990	1
1998	1
1999	2
2000	4
2001	5
2002	8
2003	12
2004	10
2005	10
2006	11
2007	12
2008	11
2009	9
2010	11
2011	12
2012	15
2013	9
2014	8
2015	11
2016	11
2017	5
2018	12
2019	5
2020	4
2021	8
2022	2
2023	2
2024	0

1

Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels.

Castagna MG, Brilli L, Pilli T, Montanaro A, Cipri C, Fioravanti C, Sestini F, Capezzone M, Pacini F. Castagna MG, et al. J Clin Endocrinol Metab. 2008 Jan;93(1):76-81. doi: 10.1210/jc.2007-1404. Epub 2007 Oct 30. J Clin Endocrinol Metab. 2008. PMID: 17971424

2

Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures.

Giovanella L, Ceriani L, Ghelfo A, Keller F, Sacchi A, Maffioli M, Spriano G. Giovanella L, et al. Clin Chem Lab Med. 2006;44(5):648-52. doi: 10.1515/CCLM.2006.107. Clin Chem Lab Med. 2006. PMID: 16681439

3

Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma.

Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, Lippi F, Taddei D, Grasso L, Pinchera A. Pacini F, et al. J Clin Endocrinol Metab. 2003 Aug;88(8):3668-73. doi: 10.1210/jc.2002-021925. J Clin Endocrinol Metab. 2003. PMID: 12915653

4

Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?

Vera P, Kuhn-Lansoy C, Edet-Sanson A, Hapdey S, Modzelewski R, Hitzel A, d'Anjou J, Basuyau JP. Vera P, et al. Thyroid. 2010 Jan;20(1):15-23. doi: 10.1089/thy.2008.0416. Thyroid. 2010. PMID: 20017617

5

Predictive value of recombinant human TSH stimulation and neck ultrasonography in differentiated thyroid cancer patients.

Crocetti U, Durante C, Attard M, Maniglia A, Tumino S, Bruno R, Bonfitto N, Dicembrino F, Varraso A, Meringolo D, Filetti S, Trischitta V, Torlontano M. Crocetti U, et al. Thyroid. 2008 Oct;18(10):1049-53. doi: 10.1089/thy.2008.0160. Thyroid. 2008. PMID: 18816184

6

Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.

Pacini F, Molinaro E, Lippi F, Castagna MG, Agate L, Ceccarelli C, Taddei D, Elisei R, Capezzone M, Pinchera A. Pacini F, et al. J Clin Endocrinol Metab. 2001 Dec;86(12):5686-90. doi: 10.1210/jcem.86.12.8065. J Clin Endocrinol Metab. 2001. PMID: 11739420

7

Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up.

Chindris AM, Diehl NN, Crook JE, Fatourechi V, Smallridge RC. Chindris AM, et al. J Clin Endocrinol Metab. 2012 Aug;97(8):2714-23. doi: 10.1210/jc.2011-3017. Epub 2012 May 25. J Clin Endocrinol Metab. 2012. PMID: 22639286

8

Do thyroid cancer patients with basal undetectable Tg measured by current immunoassays require rhTSH testing?

Díaz-Soto G, Puig-Domingo M, Martínez-Pino I, Martínez de Osaba MJ, Mora M, Rivera-Fillat F, Halperin I. Díaz-Soto G, et al. Exp Clin Endocrinol Diabetes. 2011 Jun;119(6):348-52. doi: 10.1055/s-0030-1269881. Epub 2011 Jan 24. Exp Clin Endocrinol Diabetes. 2011. PMID: 21264807

9

The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels.

Pellegriti G, Scollo C, Regalbuto C, Attard M, Marozzi P, Vermiglio F, Violi MA, Cianci M, Vigneri R, Pezzino V, Squatrito S. Pellegriti G, et al. Clin Endocrinol (Oxf). 2003 May;58(5):556-61. doi: 10.1046/j.1365-2265.2003.01744.x. Clin Endocrinol (Oxf). 2003. PMID: 12699436

10

A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later.

Kloos RT, Mazzaferri EL. Kloos RT, et al. J Clin Endocrinol Metab. 2005 Sep;90(9):5047-57. doi: 10.1210/jc.2005-0492. Epub 2005 Jun 21. J Clin Endocrinol Metab. 2005. PMID: 15972576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

190 results

Results by year